Contribution: Industrial Research Assistance Program – Contributions to Firms
Shiphrah Biomedical Inc.
$39,800.00
Feasibility of the PrenaBelt™ for Use in Pregnancies Affected by Obesity
FY 2021-22 · 2021-10-01
Summary
To eliminate one of the few remaining modifiable risk factors for stillbirth and low birth weight (sleeping on the back in late pregnancy), we have developed the PrenaBelt™ – the first and only clinically tested and internationally-published positional therapy device for use during sleep in pregnancy. The PrenaBelt™ currently does not support pregnancies affected by obesity; however, this population is at a higher risk of pregnancy issues, including stillbirth. Therefore, we propose a feasibility project to adapt the PrenaBelt™ solution to this unique but
rapidly growing customer segment.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Toronto|Toronto, Ontario, Canada
Recipient Type
For-profit organization
Business Number
703579110
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2021-10-01 | 2021-22 | $50,000.00 |
| 1 | 2021-10-01 | 2021-22 | $39,800.00 |
| 2 | 2021-10-01 | 2021-22 | $39,800.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 45 days.
Additional Information (French)
Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de 45 jours.
Agreement End Date
2022-10-15
Agreement Number
979351
Agreement Start Date
2021-10-01
Agreement Title
Feasibility of the PrenaBelt™ for Use in Pregnancies Affected by Obesity
Agreement Title (French)
Faisabilité de l'utilisation de la PrenaBelt™ dans les grossesses affectées par l'obésité
Agreement Type
Contribution
Agreement Value
$39,800.00
Amendment Date
2022-09-12
Amendment Number
2
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
To eliminate one of the few remaining modifiable risk factors for stillbirth and low birth weight (sleeping on the back in late pregnancy), we have developed the PrenaBelt™ – the first and only clinically tested and internationally-published positional therapy device for use during sleep in pregnancy. The PrenaBelt™ currently does not support pregnancies affected by obesity; however, this population is at a higher risk of pregnancy issues, including stillbirth. Therefore, we propose a feasibility project to adapt the PrenaBelt™ solution to this unique but
rapidly growing customer segment.
Description (French)
Pour éliminer l'un des rares facteurs de risque modifiables restants en matière de mortinatalité et d'insuffisance pondérale à la naissance (le fait de dormir sur le dos en fin de grossesse), nous avons mis au point le PrenaBelt™ - le premier et le seul dispositif de thérapie positionnelle testé cliniquement et faisant l'objet d'une publication internationale, à utiliser pendant le sommeil pendant la grossesse. Actuellement, le PrenaBelt™ ne prend pas en charge les grossesses touchées par l'obésité; or, cette population présente un risque plus élevé de problèmes de grossesse, notamment de mortinatalité. Par conséquent, nous proposons un projet de faisabilité pour adapter la solution PrenaBelt™ à ce segment de clientèle unique mais en pleine croissance.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Toronto Centre
Federal Riding (French)
Toronto-Centre
Federal Riding Number
35108
NAICS Code
3391
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
703579110
Recipient City
Toronto|Toronto
Recipient Country
CA
Recipient Legal Name
Shiphrah Biomedical Inc.
Recipient Postal Code
M5A 0B9
Recipient Province or Territory
ON
Recipient Type
F
Reference Number
172-2021-2022-Q3-979351
